Cardioversion of persistent atrial flutter in non-anticoagulated patients at low risk for thromboembolism

Italian Heart Journal

Volumn 1, Issue 5, 2000, Pages 349-353

  Bertaglia, E ^a   D'Este, D ^a   Franceschi, M ^a   Pascotto, P ^a  

^a NONE   (Italy)

Author keywords

Anticoagulation; Atrial flutter cardioversion; Thromboembolism; Transesophageal atrial overdrive pacing

Indexed keywords

ADULT; AGED; ANTICOAGULATION; ARTICLE; CARDIOVASCULAR RISK; CARDIOVERSION; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FLUTTER; HEART ATRIUM PACING; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK BENEFIT ANALYSIS; SINUS RHYTHM; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FLUTTER; CARDIAC PACING, ARTIFICIAL; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; FEMALE; HUMAN; MALE; MIDDLE AGE; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM;

EID: 0033830414     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Auricular flutter and fibrillation
2. Atrial flutter - Update on the mechanism and treatment
3. Antithrombotic therapy in atrial fibrillation
4. Placebo-controlled randomised trial of warfarin and aspirin for the prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study
5. The effect of low dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
6. Stroke prevention in atrial fibrillation study: Final results
7. Canadian Atrial Fibrillation Anticoagulation (CAFA) study
8. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
9. Thromboembolism following cardioversion of 'common' atrial flutter. Risk factors and limitations of transesophageal echocardiography
10. Risk of thromboembolism in chronic atrial flutter
11. Thromboembolism in chronic atrial flutter: Is the risk underestimated?
12. Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography
13. Risk of thromboembolic events in patients with atrial flutter
14. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)
15. To fumble flutter or tackle 'tach'? Toward updated classifiers for atrial tachyarrhythmias
16. Electrocardiographic and electrophysiologic characterization of atypical atrial flutter in man. Use of activation and entrainment mapping and implications for catheter ablation
17. Postconversion systemic arterial embolism
18. Electrical conversion of atrial fibrillation: Immediate and long-term results and selection of patients
19. Electrical reversion of cardiac arrhythmias
20. The efficacy of anticoagulant therapy in preventing embolism related to DC electrical cardioversion of atrial fibrillation
21. Evaluation of transesophageal echocardiography before cardioversion of atrial fibrillation and atrial flutter in nonanticoagulated patients
22. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: A transesophageal echocardiographic study
23. Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease
24. Prevalence of intraatrial thrombus in patients with atrial flutter
25. Delayed restoration of atrial function after conversion of atrial flutter by pacing or electrical cardioversion
26. Left atrial appendage 'stunning' after electrical cardioversion of atrial flutter: An attenuated response compared with atrial fibrillation as the mechanism for lower susceptibility to thromboembolic events
27. Left atrial 'stunning' following radiofrequency catheter ablation of chronic atrial flutter
28. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter
29. Direct-current cardioversion for the conversion of atrial flutter
30. Effect of direct current shocks on atrial mechanical function in patients with structural heart disease